Skip to main content
MS-DRG 922 · MDC 21 · Medical

MS-DRG 922: Other Injury, Poisoning and Toxic Effect Diagnoses with MCC

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: IPPS Table 5 (MS-DRG weights): v44 FY2027 (final rule + CN3) (effective October 1, 2026); MS-DRG Definitions Manual: v44 (effective October 1, 2026). Next CMS release: FY2028 final rule (August 2027), effective October 1, 2027; an April 1 interim grouper update when CMS issues one for the IPPS Table 5 (MS-DRG weights); the FY2028 grouper, effective October 1, 2027 for the MS-DRG Definitions Manual.

Key facts for DRG 922

FY2027 relative weight
1.6238
Higher than 49% of all MS-DRGs
Change vs FY2026
-7.2%
FY2026 weight 1.7494
Geometric mean LOS
3.9 days
Arithmetic mean 6.3 days
MDC
21
Injuries, Poisonings and Toxic Effects of Drugs
Severity level
with MCC (major complication or comorbidity)
National unadjusted operating payment
$11,119.78
Weight × $6,848.00 FY2027 standardized amount; capital adds $876.77
Transfer policy
Not a transfer DRG

TL;DR

MS-DRG 922 is a medical group in MDC 21 (Injuries, Poisonings and Toxic Effects of Drugs), at the higher of two severity levels in its family. CMS assigns it a FY2027 relative weight of 1.6238 with a geometric mean length of stay of 3.9 days and an arithmetic mean of 6.3. Its weight moved down 7.2% from FY2026 (1.7494). That weight is higher than 49% of all MS-DRGs. Its weight sits 62.8% above DRG 923 (without MCC, 0.9973). The v44 Definitions Manual assigns it through 2,446 principal diagnosis codes.

What changed from FY2026 to FY2027

CMS recalibrates every MS-DRG weight annually from the prior year's MedPAR claims. For DRG 922 the FY2027 relative weight is 1.6238 against 1.7494 in FY2026, a fall of 7.18%, which exceeds the 2% threshold worth re-checking in contract models.

FY2026 versus FY2027 payment factors for MS-DRG 922
MetricFY2026FY2027Change
Relative weight1.74941.6238-0.1256
Geometric mean LOS (days)4.23.9-0.3
Arithmetic mean LOS (days)7.46.3-1.1
Weights shown are the FY2027 final values after the 10% cap on year-over-year reductions where applicable.

CC and MCC family

DRG 922 shares its base definition with 1 other MS-DRG split by severity. The family's weights span 0.9973 to 1.6238, a 1.63× spread, which is the payment effect of documenting qualifying complications and comorbidities.

MS-DRGs in the same base group as DRG 922
DRGTitleFY2027 weightGMLOSNational operating payment
922Other Injury, Poisoning and Toxic Effect Diagnoses with MCC1.62383.9$11,119.78
923Other Injury, Poisoning and Toxic Effect Diagnoses without MCC0.99732.9$6,829.51

At the national rate, documenting the family's top severity level (DRG 922, $11,119.78) instead of its base level (DRG 923, $6,829.51) changes the operating payment by $4,290.27, the amount at stake when a reviewer removes the MCC or CC that put the stay here. The figures are national operating amounts before the hospital-specific adjustments described below.

National unadjusted payment for DRG 922

Multiplying the FY2027 relative weight (1.6238) by the national rates in IPPS Tables 1A and 1D, as corrected by notice CMS-1849-CN3, gives the base amounts below. Across the CC/MCC family the operating amount spans $4,290.27.

FY2027 national unadjusted IPPS payment for MS-DRG 922
ComponentNational rateDRG 922
Operating (labor and nonlabor share)$4,519.68 + $2,328.32 = $6,848.00$11,119.78
Capital (federal rate)$539.95$876.77
Operating plus capital$11,996.55
Assumes the full annual update (the hospital submitted quality data and is a meaningful EHR user). A hospital with a reduced update starts from $10,771.95 to $11,032.83 for the operating portion of this DRG.

These are national, unadjusted figures, not what a given hospital is paid. The labor share is multiplied by the hospital's wage index (Table 1A applies when the wage index is above 1.0 and Table 1B otherwise), and teaching (IME), disproportionate share (DSH), outlier, transfer and new-technology add-on rules then change the amount for each stay. Use the figures to compare groups and to size a documentation finding, not to forecast a remittance; the DRG payment calculator applies a hospital's own wage index and teaching and DSH factors to DRG 922.

Risk-adjusting diagnoses in this DRG

Appendix B of the v44 Definitions Manual lists 2,446 ICD-10-CM codes in the logic for DRG 922; 9 of them also map to a CMS-HCC V28 payment category, across 2 categories. The same documentation that supports the inpatient group feeds Medicare Advantage risk adjustment when the patient is an MA enrollee.

CMS-HCC V28 categories among the diagnoses in the logic for DRG 922
V28 HCCCategoryShared codesExamples
HCC 155Major Depression, Moderate or Severe, without Psychosis8T71.112A, T71.122A, T71.132A
HCC 2Septicemia, Sepsis, Systemic Inflammatory Response Syndrome/Shock1T79.4XXA

New for FY2027: codes that group to DRG 922

IPPS Tables 6A and 6B assign 20 new ICD-10-CM codes to DRG 922 from October 1, 2026. Encoders and edit tables that still run the v43 code set reject these codes or group them elsewhere, so check them first when a FY2027 discharge in this DRG fails an edit. The FY2027 ICD-10 code-change report lists every addition and deletion with its CC level and MS-DRGs.

New FY2027 ICD-10-CM codes that group to DRG 922
ICD-10-CMDescriptionSeverity
T52.811SToxic effect of alkenes, accidental (unintentional), sequelanon-CC
T52.812SToxic effect of alkenes, intentional self-harm, sequelanon-CC
T52.813SToxic effect of alkenes, assault, sequelanon-CC
T52.814SToxic effect of alkenes, undetermined, sequelanon-CC
T52.821SToxic effect of cycloparaffins, accidental (unintentional), sequelanon-CC
T52.822SToxic effect of cycloparaffins, intentional self-harm, sequelanon-CC
T52.823SToxic effect of cycloparaffins, assault, sequelanon-CC
T52.824SToxic effect of cycloparaffins, undetermined, sequelanon-CC
T52.891SToxic effect of other organic solvents, accidental (unintentional), sequelanon-CC
T52.892SToxic effect of other organic solvents, intentional self-harm, sequelanon-CC
T52.893SToxic effect of other organic solvents, assault, sequelanon-CC
T52.894SToxic effect of other organic solvents, undetermined, sequelanon-CC
T59.821SToxic effect of hexamethylene diisocyanate, accidental (unintentional), sequelanon-CC
T59.822SToxic effect of hexamethylene diisocyanate, intentional self-harm, sequelanon-CC
T59.823SToxic effect of hexamethylene diisocyanate, assault, sequelanon-CC
First 15 of 20 shown.

Grouper logic (v44 Definitions Manual)

The manual's split table for Other Injury, Poisoning and Toxic Effect Diagnoses gives one row per combination of criteria and the MS-DRG it assigns. DRG 922 is the row where MCC is Yes.

Split table for Other Injury, Poisoning and Toxic Effect Diagnoses
MCCDRG
Yes922
No923

Principal Diagnosis: 2446 ICD-10-CM codes in this DRG's assignment logic; the first 12 are shown.

Principal Diagnosis codes in the logic for DRG 922 (sample)
ICD-10-CM codeDescription
M97.01XSPeriprosthetic fracture around internal prosthetic right hip joint, sequela
M97.02XSPeriprosthetic fracture around internal prosthetic left hip joint, sequela
M97.11XSPeriprosthetic fracture around internal prosthetic right knee joint, sequela
M97.12XSPeriprosthetic fracture around internal prosthetic left knee joint, sequela
M97.21XSPeriprosthetic fracture around internal prosthetic right ankle joint, sequela
M97.22XSPeriprosthetic fracture around internal prosthetic left ankle joint, sequela
M97.31XSPeriprosthetic fracture around internal prosthetic right shoulder joint, sequela
M97.32XSPeriprosthetic fracture around internal prosthetic left shoulder joint, sequela
M97.41XSPeriprosthetic fracture around internal prosthetic right elbow joint, sequela
M97.42XSPeriprosthetic fracture around internal prosthetic left elbow joint, sequela
M97.8XXSPeriprosthetic fracture around other internal prosthetic joint, sequela
M97.9XXSPeriprosthetic fracture around unspecified internal prosthetic joint, sequela

Code editor, HAC and CC/MCC exclusion notes for DRG 922

Because this family splits by CC and MCC, a secondary diagnosis on the hospital-acquired condition list that is reported with a present-on-admission indicator of N or U does not count toward the severity level, and a CC or MCC excluded by the principal diagnosis does not count either. Check a secondary diagnosis and its CC exclusion before relying on it for the higher member.

The Definitions Manual lists the diagnosis and procedure codes that lead to DRG 922; these are the ones that are also on a Medicare Code Editor list and can draw that edit.

Medicare Code Editor v44 lists that include codes in the logic of DRG 922
MCE editListCodesExamples
Edit 4age conflict: pediatric diagnosis (age 0 to 17)34T74.02XA, T74.02XS, T74.12XA
Edit 4age conflict: adult diagnosis (age 15 to 124)32T74.01XA, T74.01XS, T74.11XA
Edit 9unacceptable principal diagnosis188T36.0X5S, T36.1X5S, T36.2X5S
Edit 20unspecified code where a laterality-specific code exists25T33.019A, T33.40XA, T33.519A

Documentation and denial exposure

As a medical DRG, assignment depends on the principal diagnosis sequenced from the attending's documentation; a secondary condition sequenced first, or a symptom code in place of the confirmed diagnosis, changes the MDC or the DRG. Because this family splits by severity, auditors target CC and MCC capture: each secondary diagnosis must be documented as present, monitored, evaluated or treated during the stay to survive a DRG-validation review. Typical inpatient denial codes for this group: CARC 16 (claim lacks information needed to group the stay), CARC 50 (the admission or procedure is judged not medically necessary), CARC 97 (a service is bundled into the DRG payment).

For teams evaluating QuickIntell software

Evaluate a documentation and coding workflow for DRG 922

Explore QuickCode for qualified coder review and documentation clarification, or QuickScribe for clinician-reviewed visit documentation. Confirm inpatient scope, the supported grouper version and reviewer responsibilities during evaluation. This public reference is not a production grouper and does not determine a claim's reimbursement.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — DRG 922

What is MS-DRG 922?

MS-DRG 922 is "Other Injury, Poisoning and Toxic Effect Diagnoses with MCC", a medical Medicare Severity Diagnosis-Related Group in MDC 21 (Injuries, Poisonings and Toxic Effects of Drugs). Medicare pays inpatient stays grouped here at the hospital's base rate multiplied by the DRG relative weight.

What is the FY2027 relative weight for DRG 922?

The FY2027 relative weight is 1.6238 (IPPS final rule Table 5, effective October 1, 2026). In FY2026 it was 1.7494, a change of -7.2%.

What is the Medicare base payment for MS-DRG 922?

$11,119.78 for operating costs plus $876.77 for capital, $11,996.55 together, at the FY2027 national rates: weight 1.6238 times the $6,848.00 operating standardized amount and the $539.95 capital rate (IPPS Tables 1A and 1D as corrected by CMS-1849-CN3). DRG 923 (without MCC) comes to $6,829.51 operating on the same basis. The hospital's wage index, IME, DSH, outlier and transfer adjustments change what a given stay is paid.

What is the average length of stay for DRG 922?

CMS reports a geometric mean length of stay of 3.9 days and an arithmetic mean of 6.3 days for FY2027. The geometric mean is used for transfer-payment calculations.

Which DRGs are in the same CC/MCC family as 922?

DRG 923 (without MCC, weight 0.9973, GMLOS 2.9 days). Together with DRG 922 the family spans 0.9973 to 1.6238, a 1.63x spread, so documented complications and comorbidities change payment materially.

What documentation supports the severity level of DRG 922?

DRG 922 requires at least one secondary diagnosis on the CMS Major Complication or Comorbidity list, documented as present and clinically addressed during the stay (monitored, evaluated, treated or extending the stay). Conditions such as acute respiratory failure, severe sepsis or acute kidney injury with specified cause qualify only when the attending's note states the diagnosis itself, not just the lab values. Recovery auditors downgrade this group to the CC or base level when the MCC rests on an unconfirmed query or a resolved historical condition, so the query response and the discharge summary must agree.

Which codes group to DRG 922?

The v44 Definitions Manual lists 2,446 principal diagnosis codes for this group. Examples from the principal diagnosis list, M97.41XS (Periprosthetic fracture around internal prosthetic right elbow joint, sequela); M97.42XS (Periprosthetic fracture around internal prosthetic left elbow joint, sequela); M97.8XXS (Periprosthetic fracture around other internal prosthetic joint, sequela); M97.9XXS (Periprosthetic fracture around unspecified internal prosthetic joint, sequela).

Is DRG 922 a post-acute transfer DRG?

No. DRG 922 is not on the FY2027 post-acute care transfer list, so the transfer per-diem policy does not apply to it.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from the CMS IPPS FY2027 final rule (Table 5) and the v44 ICD-10 MS-DRG Definitions Manual. Relative weights are national factors; actual payment depends on each hospital's wage-adjusted base rate, add-ons, outliers and transfer adjustments. Nothing here is legal, clinical or billing advice; verify grouping against your encoder and the published CMS files.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.